课题基金 / 基金详情

Regional Gene Therapy to Enhance Bone Repair

Regional Gene Therapy to Enhance Bone Repair
增强骨修复的区域基因治疗
批准号:
6497422
负责人:
JAY R. LIEBERMAN
金额:
$32.64万
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-04-01 至 2005-01-31

项目摘要

项目成果

JAY R. LIEBERMAN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (Verbatim from the Applicant): Regional gene therapy is a novel approach to enhance bone repair in humans. There is concern that a single exposure to exogenous recombinant protein may not induce a satisfactory osteoinductive stimulus in patients with significant bone loss. In previous work, we have demonstrated the efficacy of an ex vivo gene transfer strategy using BMP-2-producing rat bone marrow cells created via adenoviral gene transfer. These cells were used to heal a critical-sized femoral defect in rats. Our goal now is to further explore the potential of regional gene therapy so we can better adapt this technology for humans. The plan is to enhance our understanding of the biology of the bone repair process with ex vivo gene transfer by assessing the duration of BMP production in vivo and localizing the BMP secretion in the defect site over time. In addition, the role of the transduced bone marrow cells and host cells in the bone repair process will be determined, evaluating both the immune response to gene therapy and the presence of adenovirus at various anatomic sites. The research proposed in Specific Aim 1 will evaluate another cell type (skin fibroblasts) as a potential cellular delivery vehicle to heal critical-sized bone defects. The research proposed in Specific Aim 2 will investigate the efficacy of the ex vivo adenoviral gene transfer in a more stringent and clinically relevant model by trying to heal femoral defects in adult (12 month old) and elderly (18 month old) rats. In both Specific Aims 1 and 2, the duration of BMP production in vivo and the localization of BMP in the defect will be assessed. In Specific Aim 3, the role of the BMP-2-producing bone marrow cells in the bone repair process and the donor cells will be assessed in a mouse model. In Specific Aim 4, we will: (a) compare the efficacy of the ex vivo gene transfer strategy with BMP-2-producing bone marrow cells and direct in vivo injection of the virus; and (b) compare the safety and toxicity of these two gene therapy strategies. This proposed research will enhance our knowledge with respect to the potential pitfalls of gene therapy in enhancing bone repair and hopefully take us a step closer to adapting this technology for use in humans.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Regional Gene Therapy to Enhance Bone Repair
The Use of Regional Gene Delivery to Heal Critical Sized Bone Defects
Regional Gene Therapy to Enhance Bone Repair
  • 批准号:
    9238335
  • 项目类别:
  • 资助金额:
    $60.48万
  • 财政年份:
    2010
  • 负责人:
    JAY R. LIEBERMAN
  • 依托单位:
The Use of Regional Gene Delivery to Heal Critical Sized Bone Defects
  • 批准号:
    8662546
  • 项目类别:
  • 资助金额:
    $31.32万
  • 财政年份:
    2010
  • 负责人:
    JAY R. LIEBERMAN
  • 依托单位:
海外基金